The deal comes amid an uptick in so-called SPAC deals, which had fallen out of favor due to poor returns and increased ...

The brain drug developer is continuing a trial despite a recommendation it be stopped for futility. Elsewhere, Eli Lilly ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax ...

The meeting, which helps the FDA give guidance to vaccine makers on which flu strains to target, is the second to be ...

The Trump administration’s plans to reduce NIH grant funding could have long-term consequences for the U.S. drug industry, ...

The funding comes as Eikon, run by former Merck research chief Roger Perlmutter, has started a Phase 3 trial testing one of ...

The British drugmaker claimed study success in a first-line setting in breast cancer. Elsewhere, Rezdiffra sales continued to ...

Woven Health Collective elevates clients’ science, engages the right stakeholders, and magnifies success with a harmonized and highly specialized approach across key areas. All services are backed by ...

"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...

Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...

Verve offered few details on the early end of a collaboration the companies inked in 2022, saying only that Vertex cited “changing priorities.” ...